D C Tormey

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

D. Craig Allred, Gary M. Clark, Amol Tandon et al. · Journal of Clinical Oncology · 1992 · 458 citations

Medicine, Oncology, Pathology +14

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

Thomas J. Saphner, D C Tormey, Richard Gray · Journal of Clinical Oncology · 1991 · 404 citations

Medicine, Oncology, Breast Oncology +10

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

C G Moertel, Thomas R. Fleming, J. S. Macdonald et al. · Journal of Clinical Oncology · 1995 · 374 citations

Medicine, Oncology, Pharmacotherapy +15

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

Philip Bonomi, Dianne M. Finkelstein, John C. Ruckdeschel et al. · Journal of Clinical Oncology · 1989 · 323 citations

Medicine, Oncology, Pharmacology +13

Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.

Barbara Fowble, Robert J. Gray, Kennedy W. Gilchrist et al. · Journal of Clinical Oncology · 1988 · 205 citations

Medicine, Oncology, Breast Oncology +16